当前位置: X-MOL 学术JAMA Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
JAMA Neurology ( IF 29.0 ) Pub Date : 2023-02-27 , DOI: 10.1001/jamaneurol.2023.0010
Enric Monreal, José Ignacio Fernández-Velasco, María Isabel García-Sánchez, Susana Sainz de la Maza, Sara Llufriu, Roberto Álvarez-Lafuente, Bonaventura Casanova, Manuel Comabella, Lluís Ramió-Torrentà, José Enrique Martínez-Rodríguez, Luis Brieva, Albert Saiz, Sara Eichau, José María Cabrera-Maqueda, Noelia Villarrubia, Mercedes Espiño, Francisco Pérez-Miralles, Xavier Montalbán, Mar Tintoré, Ana Quiroga-Varela, María Inmaculada Domínguez-Mozo, Fernando Rodríguez-Jorge, Juan Luís Chico-García, Daniel Lourido, José Carlos Álvarez-Cermeño, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar

The value of serum neurofilament light chain (sNfL) levels for predicting long-term disability in patients with multiple sclerosis (MS) remains controversial.

中文翻译:

未接受高效药物治疗的首次脱髓鞘性多发性硬化症患者疾病发作时血清神经丝轻链水平与残疾恶化的关联。

血清神经丝轻链 (sNfL) 水平预测多发性硬化症 (MS) 患者长期残疾的价值仍然存在争议。
更新日期:2023-02-27
down
wechat
bug